What Is Gastric Hypomotility
Gastric hypomotility is a condition in which the stomach muscles contract too slowly or weakly to move food through the digestive tract effectively. It is often linked to delayed gastric emptying, functional dyspepsia, and gastroparesis, and it can cause nausea, bloating, early satiety, and abdominal pain. The condition is diagnosed using gastric emptying scintigraphy, wireless motility capsules, and manometry, with prevalence rising in patients with diabetes, Parkinson's disease, and post-surgical complications research on gastric motility disorders.
Healthcare systems track gastric hypomotility through hospital discharge databases and gastroenterology registries, revealing higher rates among women, older adults, and individuals with long-standing diabetes. In the United States, gastroparesis-related hospitalizations increased over the past decade, and the condition is frequently coded alongside other gastrointestinal dysmotility diagnoses. Clinical guidelines from the American Gastroenterological Association emphasize objective testing and ruling out mechanical obstruction before confirming a diagnosis of gastric hypomotility AGA guidelines on gastroparesis.
Symptoms and Diagnostic Methods
Common Symptoms and Patient Impact
The most common symptoms of gastric hypomotility include persistent nausea, vomiting of undigested food, postprandial fullness, abdominal distension, and weight loss. Patients often report unpredictable symptom flares that interfere with work attendance, daily activities, and nutritional intake. In severe cases, gastric hypomotility leads to dehydration, electrolyte imbalances, and malnutrition requiring enteral or parenteral support Mayo Clinic overview of gastroparesis symptoms.
Diagnostic Tests and Procedures
Diagnosis typically begins with a clinical history and physical exam, followed by objective tests such as gastric emptying scintigraphy, the wireless motility capsule, and antroduodenal manometry. Gastric emptying scintigraphy remains the gold standard, measuring the percentage of a standardized meal retained in the stomach at four hours. The wireless motility capsule records pH, pressure, and transit times as it travels through the gastrointestinal tract, providing data on gastric, small bowel, and colonic transit motility testing in gastroenterology.
Treatment Options and Market Context
Current Treatment Approaches
Treatment for gastric hypomotility focuses on dietary modification, prokinetic medications, antiemetics, and, in refractory cases, gastric electrical stimulation or surgical interventions. Dietary strategies include small, low-fat, low-fiber meals and liquid nutrition supplements, while medications such as metoclopramide, domperidone, and erythromycin aim to enhance gastric motility. Gastric electrical stimulation devices, such as the Enterra Therapy system, are implanted in patients with severe gastroparesis who do not respond to medical therapy, and clinical trials show improvements in nausea and vomiting scores FDA PMA for gastric electrical stimulation.
Pharmaceutical and Device Market Trends
The market for prokinetic agents and gastric motility devices is shaped by regulatory approvals,